Lukas Scheibler - Sep 6, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Research Officer
Signature
/s/ David Watson, attorney-in-fact for Lukas Scheibler
Stock symbol
APLS
Transactions as of
Sep 6, 2023
Transactions value $
-$75,526
Form type
4
Date filed
9/7/2023, 04:08 PM
Previous filing
Feb 22, 2023
Next filing
Dec 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$75.5K -1.76K -2.51% $43.01 68.3K Sep 6, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This includes 412 shares from 04/30/2023 ESPP purchase.